The APAC Advantages
Summary: Asia-Pacific (APAC) has been a steadily growing area for sponsors to conduct clinical studies. Developing an efficient supply strategy can be challenging as a result of widespread differences across the region. When COVID-19 emerged, sponsors had to quickly handle supply chain disruptions while ensuring that all regional considerations were kept in mind. Partnering with a clinical supply provider who has local APAC expertise can be invaluable in order to ensure the reliable supply of clinical materials to patients across the region both during and beyond the pandemic.
This article originally appeared in the February 2021 publication of “International Clinical Trials.”